Centrient is a leading manufacturer of Beta-Lactam Antibiotics and a provider of next-generation Statins and Antifungals.
01 1CENTRIENT PHARMACEUTICALS NETHERLANDS B.V. Delft NL
02 1Teva Pharmaceuticals Usa, Inc. Mexico US
03 2ACS DOBFAR S.P.A. Tribiano IT
04 1ANTIBIÓTICOS DE LEÓN S.L.U León ES
05 1APITORIA PHARMA PRIVATE LIMITED Hyderabad IN
06 1AUROBINDO PHARMA LIMITED Hyderabad IN
07 1LUPIN LIMITED Mumbai IN
08 1ORCHID PHARMA LIMITED Alathur IN
09 1Ranbaxy Laboratories Limited Gurgaon IN
10 1SURYA PHARMACEUTICAL LTD. Chandigarh IN
11 1UNIMARK REMEDIES LIMITED Mumbai IN
01 9Cefalexin monohydrate
02 1Cefalexin monohydrate, (Enzymatic process)
03 1Cefalexin monohydrate, Powder and compacted
04 1Cefalexin monohydrate, Powder, compacted
01 7India
02 1Israel
03 2Italy
04 1Netherlands
05 1Spain
01 1Expired
02 1Suspended by Holder
03 8Valid
04 1Withdrawn by EDQM Failure to CEP procedure
05 1Withdrawn by Holder
Centrient is a leading manufacturer of Beta-Lactam Antibiotics and a provider of next-generation Statins and Antifungals.
Centrient is a leading manufacturer of Beta-Lactam Antibiotics and a provider of next-generation Statins and Antifungals.
Cefalexin Monohydrate, Powder, Compacted
Certificate Number : CEP 1997-007 - Rev 08
Status : Valid
Issue Date : 2024-06-12
Type : Chemical
Substance Number : 708
TAPI offers customized CDMO Solutions for API development and manufacturing services.
TAPI offers customized CDMO Solutions for API development and manufacturing services.
Certificate Number : R1-CEP 2000-054 - Rev 00
Status : Valid
Issue Date : 2009-06-17
Type : Chemical
Substance Number : 708
Certificate Number : CEP 1996-099 - Rev 04
Status : Valid
Issue Date : 2023-12-06
Type : Chemical
Substance Number : 708
Cefalexin Monohydrate, (Enzymatic Process)
Certificate Number : R1-CEP 1997-128 - Rev 03
Status : Valid
Issue Date : 2019-08-16
Type : Chemical
Substance Number : 708
Certificate Number : R1-CEP 2003-166 - Rev 02
Status : Valid
Issue Date : 2015-02-16
Type : Chemical
Substance Number : 708
Certificate Number : CEP 2005-001 - Rev 03
Status : Valid
Issue Date : 2023-12-15
Type : Chemical
Substance Number : 708
Certificate Number : R0-CEP 2002-251 - Rev 01
Status : Expired
Issue Date : 2005-09-22
Type : Chemical
Substance Number : 708
Certificate Number : R1-CEP 2010-193 - Rev 01
Status : Valid
Issue Date : 2021-05-11
Type : Chemical
Substance Number : 708
Cefalexin Monohydrate, Powder And Compacted
Certificate Number : CEP 2001-440 - Rev 05
Status : Valid
Issue Date : 2024-09-06
Type : Chemical
Substance Number : 708
Certificate Number : R0-CEP 2010-140 - Rev 00
Status : Withdrawn by EDQM Failure to CEP pro...
Issue Date : 2012-04-16
Type : Chemical
Substance Number : 708
A Cephalexin Monohydrate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Cephalexin Monohydrate, including repackagers and relabelers. The FDA regulates Cephalexin Monohydrate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Cephalexin Monohydrate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Cephalexin Monohydrate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Cephalexin Monohydrate supplier is an individual or a company that provides Cephalexin Monohydrate active pharmaceutical ingredient (API) or Cephalexin Monohydrate finished formulations upon request. The Cephalexin Monohydrate suppliers may include Cephalexin Monohydrate API manufacturers, exporters, distributors and traders.
click here to find a list of Cephalexin Monohydrate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Cephalexin Monohydrate CEP of the European Pharmacopoeia monograph is often referred to as a Cephalexin Monohydrate Certificate of Suitability (COS). The purpose of a Cephalexin Monohydrate CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Cephalexin Monohydrate EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Cephalexin Monohydrate to their clients by showing that a Cephalexin Monohydrate CEP has been issued for it. The manufacturer submits a Cephalexin Monohydrate CEP (COS) as part of the market authorization procedure, and it takes on the role of a Cephalexin Monohydrate CEP holder for the record. Additionally, the data presented in the Cephalexin Monohydrate CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Cephalexin Monohydrate DMF.
A Cephalexin Monohydrate CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Cephalexin Monohydrate CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Cephalexin Monohydrate suppliers with CEP (COS) on PharmaCompass.
We have 10 companies offering Cephalexin Monohydrate
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
